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Community pharmacists’ Contribution to public health: assessing the global 
evidence base  
Abstract 
In the UK, community pharmacies are more accessible to the general population than general 
practices. Therefore, government white papers and briefing documents from pharmacy professional 
bodies have advocated the expansion of the role of community pharmacists, particularly in relation to 
the provision of services that contribute to disease prevention and health improvement. It is unknown 
whether the same evidence exists globally for the expansion of these roles. 
This article attempts to appraise and summarise the global evidence for the public health roles that 
community pharmacists play. Barriers, as well as strategies that can enhance these roles, are also 
discussed. 
Electronic databases were searched to retrieve relevant literature published since 1 January 2000. The 
selected literature included 2 meta-analyses, 7 literature reviews, 23 interventional studies and 41 
descriptive studies. These were assessed according to health topics (i.e. smoking cessation, weight 
management, health promotion, disease screening and preventive activities, vaccination and 
immunisation, alcohol dependence advice and drug misuse, emergency hormonal contraception, and 
sexual health services). 
The effectiveness of community pharmacy-based public health interventions was shown in smoking 
cessation, health promotion, disease screening and preventive activities, provision of emergency 
hormonal contraceptive, and vaccination services. Although there was mixed evidence with respect 
to weight management and alcohol dependence advice interventions, the available data suggest 
feasibility and acceptability of these services due to the perceived ease of access and convenience. 
Key points: 
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 The effectiveness of community pharmacy-based public health interventions was shown in 
smoking cessation, health promotion, disease screening and preventive activities, provision 
of emergency hormonal contraceptive, and vaccination services. 
 Overall, the evidence demonstrates that pharmacists are capable of providing both 
population-based and individual level public health services.  
 However, strategies that can help facilitate and enhance community pharmacists’ public 
health roles are needed. 
 Further studies on cost-effectiveness of community pharmacists’ public health intervention 
are also needed. 
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Introduction 
The World Health Organization (WHO) defines health as “A state of complete physical, mental and 
social wellbeing, and not merely the absence of infirmity”[1]. The main determinants of health include 
non-modifiable factors (e.g. age, sex and hereditary factors) and modifiable factors (e.g. individual 
lifestyle, social and community influences, living and working conditions, and general socio-economic, 
cultural and environmental conditions)[2]. Since these determinants were identified, there has been 
increased awareness of health as a global issue[3]. 
The UK Faculty of Public Health (FPH) defines public health as “The science and art of promoting and 
protecting health and wellbeing, preventing ill health and prolonging life through the organised efforts 
of society”[4]. Based on the FPH definition, public health is seen as population based; is focused on a 
collective responsibility for health, health protection and disease prevention; recognises the 
important role of the state, along with socio-economic and wider determinants of health; and stresses 
partnerships with all those whose actions contribute to the health of the population[4]. The FPH 
recognises three key domains of public health practice: health improvement, improving services and 
health protection. According to the WHO, activities that enhance public health capacities and services 
provide conditions that enable individuals to continue to be healthy, improve their wellbeing, or 
prevent the worsening of their health[5]. Therefore, public health focuses on the entire spectrum of 
health and wellbeing, not just the eradication of specific diseases[5]. While a number of activities are 
directed at specific populations (e.g. health campaigns), public health services also involve the 
provision of personal services, such as vaccinations, behavioural counselling and health advice [5]. 
 
Pharmaceutical public health is defined as “The application of pharmaceutical knowledge, skills and 
resources to the science and art of preventing disease, prolonging life, promoting, protecting and 
improving health for all, through organised efforts of society”[6]. British government white papers 
have advocated for the expansion of the role of the community pharmacist, particularly in relation to 
the provision of public health services [7], [8], [9], [10]. A key driver for this has been the increasing 
recognition of community pharmacists as one of the most accessible healthcare professionals with the 
ability to mitigate inequitable access to health services [11], [12], [13], [14]. One British government 
report indicates that >90% of the general population will visit a community pharmacy at least once in 
a given year [12]. Reports also show that health services in community pharmacies are more accessible 
to the general population than general practices in the UK, with the majority of the population living 
within a 20-minute walk of a community pharmacy[15],[16]. Community pharmacists are also readily 
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available and equipped with the knowledge and skills needed to meet the health-seeking behaviour 
of the society served, especially in relation to early disease prevention, health protection and health 
improvement[8],[12]. 
 
Even though pharmacy practice and education have evolved from an initial narrow, product-centred 
model to the present patient-centred model, it has done so to a varying degree in different countries 
[17]. While a number of meta-analyses and systematic literature reviews on the public health 
initiatives delivered by community pharmacists have been published in recent years[18],[19], these 
publications have primarily focused on the effectiveness of specific public health activities, such as 
smoking cessation[18],[19]; alcohol use, dependence and weight management[18]; and 
vaccination[20]. Some of these have focused on specific countries or regions [21]. This article aims to 
provide an overview of the global evidence (including UK studies) on the public health contributions 
of community pharmacists. Barriers, as well as strategies that can enhance these roles, will also be 
discussed. 
Methods  
The electronic databases SCOPUS, Web of Science, OvidSP, PubMed, MEDLINE and CINAHL were 
searched for relevant literature published since 1 January 2000. The keywords used were a 
combination of: community pharmacy, pharmacist, public health, health promotion, health 
improvement, health protection, disease prevention, and disease screening. A free text search using 
Boolean operators [OR & AND] to combine words was conducted for the databases. Keyword 
truncation (i.e. pharm* and public*) was also utilised to ensure all relevant articles were included in 
the search. Keyword searches were also conducted on the Google Scholar platform. The reference 
lists of retrieved literature were further searched for relevant articles. A schematic of the literature 
selection process using Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) 
is presented in Figure 1. Studies included were those that reported: effectiveness, cost-effectiveness, 
and overall involvement of community pharmacists’ public health activities. These included 
interventional, descriptive, and public health evaluation studies involving community pharmacists. 
Studies on public health initiatives or activities not based in a community pharmacy setting, editorials 
and research papers that did not include a clearly defined population, intervention or target group 
were excluded. 
Data Extraction  
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Two of the review authors (AU and CA) independently screened all identified titles and their abstracts 
for relevance (n= 3,442). Full-paper manuscripts (n=530) were then screened against the inclusion and 
exclusion criteria by AU, CA and EK, with the outcomes compared by JO-O to confirm consistency. The 
final list of selected papers was further assessed by JO-O to confirm the relevance of the identified 
studies with discrepancies resolved via consensus. 
Results 
In total, 73 articles were selected and included in this review. Evidence from systematic reviews and 
meta-analyses of community pharmacy-based public health interventions were reviewed according 
to published guidelines [22], [23], [24], [25]. Original articles already included in existing meta-analysis 
and systematic reviews selected for this paper were not further reviewed. The selected papers (see 
Table 1) were graded according to the quality of evidence grading system used in other published 
public health literature [21], [26], [27]: 
 Level A: Evidence from meta-analyses or systematic reviews that included at least one 
randomised controlled trial (RCT); 
 Level B: Evidence from individual RCTs or non-RCT, experimental or interventional studies, 
and individual non-experimental studies; 
 Level C: Descriptive and other research or evaluation not in level B, including case studies and 
examples of good practice; 
 Level D: Summary review articles and discussion of relevant literature and conference 
proceedings not otherwise classified; 
 Level E: Expert opinion, case reports, focus groups or qualitative studies. 
The selected literature included 2 meta-analyses, 7 literature reviews, 23 interventional and 41 
descriptive studies (see Table 1). Evidence from the literature is presented according to health topics, 
including smoking cessation, weight management, health promotion, disease screening and 
preventive activities, vaccination and immunisation, alcohol dependence advice and drug misuse, 
emergency hormonal contraception and sexual health services. Other papers that reported 
perceptions and barriers to community pharmacists’ involvement in public health activities, as well as 
strategies that can enhance their public health roles, are also presented under the respective themes. 
The reviews by Brown et al [18] and Anderson et al [27] covered multiple public health topics; their 
findings are reported according to the themes of this paper, as shown in Table 1. 
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Figure 1: Schematic of literature selection process using the Preferred Reporting Items for Systematic 
Reviews and Meta-Analysis (PRISMA)  
Full text articles assessed for eligibility 
(n=530) 
Literature identified through search 
of electronic databases (n=29644) 
Additional records identified through 
other sources (n=13) 
 
Full text articles excluded after screening against the 
inclusion/exclusion criteria (n=457). 
Studies from other primary care and/or pharmacy practice 
settings, evaluations of pharmaceutical care services, 
commentaries, editorials, or those that explicitly involved 
therapeutic management of chronic diseases were excluded.  
 
 
Records after duplicates removed (n=14898) 
 
Records limited from year 2000 to present and screened 
by title and abstract (n=3442) 
Studies included in review (n= 73) 
 
 
Records excluded (n=2912) 
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*Reviewed multiple public health topics with the findings reported according to themes in this paper 
  
Table 1: Summary of Included papers 
Public Health 
Themes  
Publication/study 
Type (N) 
Author/year Design Country (N) Level of 
Evidence  
Summary 
Smoking 
cessation 
(N=12) 
 Meta-analysis (2) Saba et al 2014 Included 3 RCT, 2 
before/after 
studies with 
control group   
Sweden (1), UK (3), USA 
(1),  
Level A 
 
 
 
Conclusive evidence on the 
effectiveness of smoking cessation 
services delivered by community 
pharmacists.  Cessation 
interventions that included 
provision of behavioural 
modification counselling were 
more effective. Time pressures 
and non-availability of 
appropriate training limited 
implementation of service in 
community pharmacies. 
*Brown et al 2016 Included 10RCT, 1 
nRCT, 1 
before/after study 
with control group   
Australia (2), Japan (1), 
Canada (1), UK (4), USA 
(2), Netherlands (1) 
Denmark (1) 
Literature review 
(2) 
*Anderson et al 2003   Included 2RCT, 3 
nRCT 
Sweden (1), Germany 
(1), UK (2), Switzerland 
(1)  
Level A 
Agomo 2012 Included 4 Surveys, 
1 report, 3 
reviews, I guideline 
document 
UK (4), USA (3), Malaysia 
(1), Turkey (1) 
Level A 
Descriptive (8) William et al 2000, 
Çalgan 2007, 
Thananithisak et al 
2008, Nimpitakpong 
et al 2010, Hoch et al 
2012, Mohamed et al 
2013, Kurko et al 
2010, El Hajj et al 
2012 
Cross sectional 
survey 
Qatar (1), UK (1), USA 
(1), Finland (1) Thailand 
(2), Turkey (1) and Sudan 
(1) 
Level C 
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*Reviewed multiple public health topics with the findings reported according to themes in this paper 
  
Public Health 
Themes 
Publication/study 
Type (N) 
Author/year Design (N) Country (N) Level of 
Evidence 
Summary 
Weight 
Management 
(N=7) 
Literature review 
(3) 
*Anderson et al 
2003 
One before/after 
study with no 
control group 
Denmark  Level B  
 
Available evidence demonstrates the 
feasibility and acceptability of the service, 
however the data on effectiveness is mixed 
relative to reduction in weight and BMI 
compared to other primary care settings 
and/or commercial providers. Interventions 
that included lifestyle advice on diet, physical 
activity and behavioural changes were more 
effective. Privacy concerns, time constrains 
and perceived lack of expertise and specialist 
knowledge were key barriers identified from 
consumer surveys. 
*Brown et al 
2016, 
Included 3RCT, 1 
before/after study 
with control group, 
1 nRCT 
UK (2), USA (2), 
Thailand (1) 
 
Level A 
Hermansyah et 
al 2016 
1 RCT Thailand (1) 
Intervention (1) Boardman and 
Avery 2014 
Before and after 
study with no 
control group  
UK (1) Level B 
Descriptive  
(5) 
Newlands et al 
2011, 
Weidmann et al 
2012, Um et al 
2012, Um et al 
2013, 
Weidmann et al 
2015 
Cross sectional 
survey (3), 
qualitative 
interviews (2) 
UK (3), Australia 
(2) 
Level C 
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Public Health 
Themes  
Publication/study 
Type (N) 
Author/year Design  Country (N) Level of 
Evidence  
Summary 
Health 
promotion and 
education 
campaigns 
(N=8) 
Intervention (2) Castillo-García et al 2011 Before/after 
evaluation plus 
cross sectional 
survey  
Spain  Level B Effective in improving public 
knowledge and awareness of 
targeted health related issue. 
Although pharmacists were 
generally positive about role, they 
indicated lack of knowledge and 
inadequate training limited their 
involvement in providing the service  
Murphy and Dipietro 2012  Before/after 
with no control 
group  
USA  
Descriptive (6)  
 
Laliberte et al 2012, 
Schmiedel et al 2013, 
Beshir and Bt Hamzah 
2014, Real et al 2014, 
Ayoub et al 2016, 
Mizoguchi et al 2016 
Cross sectional 
survey and one 
participatory 
research  
Malaysia (1), 
Jordan (1), Canada 
(1), Argentina (1), 
Germany (1), 
Japan (1) 
Level C 
Disease 
Screening and 
prevention 
activities 
(N=13)  
Intervention (9)  Hourihan et al 2003, 
Krass et al 2003, Krass et 
al 2007, Peterson et al 
2010, Fuller et al 2011, 
Perraudin et al 2015, 
Sushilkumar 2015, Tsuyuki 
et al 2016, Sandhu et al 
2016 
1RCT, Cohort 
study with 
follow up (8) 
Canada (2), 
Australia (4), 
France (1), New 
Zealand (1) India 
(1) 
Level B  
 
Intervention increased access and 
was effective in early identification 
of at-risk group with subsequent 
referral to physician. Also provides 
an avenue for lifestyle modification 
counselling to service users  
Descriptive (4) Watson et al 2003, Weidle 
et al 2014, Lowres et al 
2015, Schmiedel et al 
2016 
Cross sectional 
survey and one 
qualitative 
interview  
Australia (1), USA 
(1), Germany (1), 
UK (1) 
Level C 
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*Reviewed multiple public health topics with the findings reported according to themes in this paper. 
Public Health 
Themes  
Publication/study 
Type (N) 
Author/year Design Country (N) Level of 
Evidence  
Summary  
Vaccination and 
immunization 
(N=6) 
Literature review  Burson et al 
2016) 
Included 25 cross 
sectional surveys, 4 
cohort studies, 4 case 
control studies, 4 
experimental studies, 3 
modelling studies, 7 
single-subject design  
USA (47) Level A   
 
 
Data indicates that community 
pharmacists’ involvement in service 
provision improved coverage, 
expanded access and increased 
likelihood of uptake Intervention (2) Isenor et al 2016, 
Buchan et al 2017 
 Before/after with no 
control group  
Canada (2) Level B 
Descriptive (3) Valiquette and 
Bédard 2015, 
Evans et al 2016, 
Kulczycki et al 
2017 
Qualitative interviews 
and one cross sectional 
survey  
UK (1), Canada 
(1), USA (1) 
Level C 
Alcohol 
dependence 
advice and drug 
misuse services 
(N=6) 
Literature review 
(2) 
Watson and 
Blenkinsopp 2009 
3 before/after studies 
with no control group 
UK (3) Level B Limited evidence on effectiveness of 
service. The literature also reports 
poor uptake by the public and 
limited overall involvement by 
community pharmacists. This was 
primarily due to lack of training, 
adequate knowledge and 
confidence in providing the service. 
However, the evidence suggests 
feasibility and acceptability of the 
service.   
*Brown et al 2016 2 RCT UK (2) Level A 
Intervention (2) Khan et al 2013  Before/after study with 
no control group  
UK  Level B 
Cochran et al 
2016 
Cohort study   USA  
Descriptive (3) McCaig et al 
2011, Horsfield et 
al 2011, Sheridan 
et al 2012 
Cross sectional survey 
and one qualitative 
interview  
USA (1), New 
Zealand (2) 
Level C 
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Public Health 
Themes  
Publication/study 
Type (N) 
Author/year Design Country (N) Level of 
Evidence  
Summary  
Emergency 
contraception 
and sexual 
health 
 (N=4) 
Literature review 
(3)  
*Anderson et al 2003 3 before/after study 
with no control group, 2 
cross sectional surveys, 
one qualitative 
interview 
UK (4), USA (2)  Level B  
 
 
Promoted improved access to 
emergency contraception with 
users indicating they valued the 
ease and convenience of the 
service.   
Anderson and 
Blenkinsopp 2006 
Included one RCT, 5 
before/after studies, 9 
qualitative 
interviews/focus groups 
and cross sectional 
surveys  
Canada (3), Sweden 
(2), South Africa (1), 
Europe (1), France (1), 
Norway (1), Portugal 
(1) USA (6), UK (7) 
Level A 
Agomo, 2012 One RCT, 2 reviews, 
cohort study and cross 
sectional surveys 
USA (4), Belgium (1), 
UK (2) 
Level A 
Descriptive (2) Baraister et al 2007 Service evaluation plus 
qualitative interview  
UK (1) Level C 
Gale and Watson 
2011 
Cross sectional survey  UK (1) Level C 
Cost 
effectiveness 
studies  
(N=8) 
Descriptive (3) Pharmacy Research 
UK 2014, Royal 
Pharmaceutical 
Society 2014, Oswald 
& Adcock 2016 
Commissioned reports 
(3) 
UK (3) Level B  Community pharmacy-based public 
health services such as smoking 
cessation and disease screening are 
cost effective. Intervention cost are 
off-set by reduction in use of other 
health services and increased 
quality adjusted life gained (QALYs) 
 Intervention (5)  Thavorn & 
Chaiyakunapruk 
2008, Perraudin et al 
2013, Lowres et al 
2014, Wright et al 
2015a & 2015b  
Cohort studies and one 
economic modelling 
estimate  
UK (2), Thailand (1), 
France (1), Australia 
(1) 
Level B 
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*Reviewed multiple public health topics with the findings reported according to themes in this paper 
 
 
 
Public Health 
Themes  
Publication/study 
Type (N) 
Author/year Design Country (N) Level of 
Evidence  
Summary  
Perceptions, public 
views and barriers to 
implementation of 
public health 
services  
(N=5)  
Descriptive (5) Bush et al 2009, 
Agomo 2012a, 
Agomo and 
Ogunleye 2014, 
Agomo 2012c, 
Saramunee 2014 
Qualitative 
interview, focus 
group, 3 cross 
sectional surveys  
UK (5) Level C Community pharmacists generally had 
positive views about their involvement 
in public health activities. Barriers to 
participation in these services include 
time constrains, lack of training and 
inadequate knowledge and skills. 
 
Strategies that can 
enhance the public 
health roles of 
community 
pharmacists  
(N=4) 
Descriptive (4) Agomo and 
Ogunleye 2014, 
Agomo et al 
2016a, Agomo et 
al 2016b, Agomo 
et al 2016c 
Cross sectional 
survey and 
qualitative 
interview  
UK (4) Level C  Strategies that can enhance public health 
these roles of community pharmacists 
including provision of appropriate 
training, availability and familiarity with 
guidelines, availability of regulatory 
support and policies that encourage 
participation in these activities.  
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Smoking cessation services  
Two meta-analyses of community pharmacy-based smoking cessation interventions were included in 
this paper[18],[19]. The meta-analysis by Saba et al. with a total of 1,426 smokers demonstrated better 
abstinence rates in the intervention group compared with usual care (relative risk [RR]: 2.21; 95% 
confidence interval [CI]: 1.49–3.29)[19]. The paper by Brown et al., including more than 11,000 
smokers, showed higher odds to quit smoking with community pharmacists’ interventions. The odds 
of quitting varied depending on whether the metaregression model used accounted for the use of an 
active comparator group (pooled odds ratio [OR]: 1.21; 95% CI: 0.86–1.71) or a non-active and usual 
care comparator (pooled OR: 2.56; 95% CI: 1.45 to 4.53)[18]. The usual care and non-active 
comparators in the meta-analyses were primarily observation only, ad hoc smoking cessation advice, 
use of placebo nicotine patches and standard smoking cessation counselling. The findings are similar 
to the conclusions of two literature reviews that indicate community pharmacists’ smoking cessation 
initiatives are effective in helping patients stop smoking[26],[27]. The review by Anderson et al. also 
showed that interventions incorporating counselling and behavioural change methods by community 
pharmacists were more effective[27]— a finding that was supported by a scoping review[26]. Evidence 
from six survey studies indicate that community pharmacists had positive perceptions of their roles in 
providing smoking cessation services, although self-reported involvement in these activities ranged 
from 21% in Qatar[28], 39% in the United States[29], 51–71% in Thailand[30],[31], 73% in Turkey[32] 
and 76% in Sudan[33]. Two studies showed that training[34], and availability, access to and familiarity 
with smoking cessation guidelines[35] improved community pharmacists’ knowledge and involvement 
in providing smoking cessation services. 
Weight management  
Three literature reviews showed mixed evidence on the effectiveness of community pharmacy-based 
weight-management interventions [18], [21], [27]. One of the reviews concluded that although there 
was a reduction in body mass index (BMI), waist circumference and weight loss with community 
pharmacy-based weight-management interventions, the service did not result in a statistically 
significant difference in these outcomes when compared with other settings. A before/after UK study 
involving the provision of one-to-one advice and a weight loss handbook (n=281) in the intervention 
arm demonstrated a significant reduction in weight and waist circumference from baseline (mean 
change: –3.07kg and –3.87cm, respectively) [36]. The review by Anderson et al. and an Australian 
study that involved semi-structured interviews with experts demonstrates that multi-component 
community pharmacy-based weight-management interventions that included advice on diet, physical 
activity and behavioural changes were likely to be more effective[27],[37]. The review by Hermansyah 
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et al. demonstrates that while there was no improvement in BMI, waist circumference and weight for 
the intervention group that received counselling, routine monitoring and comprehensive treatment, 
their theory of planned behaviours sum score significantly increased from baseline, including the 
intention to implement healthy eating behaviour (P <0.05) and overall knowledge (6.42±1.94 to 
8.75±0.68; P <0.05) compared with the control group [21]. Overall, the weight-management services 
offered by community pharmacists included the supply of weight-loss medication and advice, 
provision of dietary and physical activity counselling, and BMI measurement [38]. Generally, 
community pharmacy staff were positive and confident about providing the service, although they 
reported that their involvement in weight-management activities were mostly opportunistic and 
customer driven [39]. A survey designed to gather the views of the general public indicated that 
community pharmacy-based weight-management services were perceived to be easier and more 
convenient to access than in GP practices, although up to a quarter of the respondents expressed 
reservations about speaking to community pharmacy staff about their weight-related concerns[40]. 
Similar findings were reported by a patient survey conducted in Australia; most of the respondents 
had never sought weight-management advice from their community pharmacist, and those who had 
done so in the past expressed their willingness to support and pay for the service[41]. However, 
respondents also viewed the service as being primarily profit driven and perceived community 
pharmacists as lacking in expertise and time [41]. 
Health Promotion Services and Educational Campaigns 
Two studies that evaluated the effectiveness of community health education campaigns delivered by 
community pharmacists demonstrate improvement in public knowledge [42] and awareness of the 
self-care needed to prevent diseases [43]. An interventional study evaluating knowledge and 
perceptions after the implementation of a similar campaign also demonstrated an increase in patient 
satisfaction and knowledge on the health issue targeted [44]. Patients who participated in the 
campaign had better perceptions of the pharmacist and recognised the community pharmacy as a 
reference point for resolving health problems [44]. Studies from Malaysia [45], Jordan [46], Argentina 
[47] and Canada [48] showed that while community pharmacists generally had positive attitudes 
about their role in health promotion and education, actual involvement in these activities was limited. 
This was in contrast to a study that showed that up to 51% of community pharmacies in a province in 
Germany conduct a health campaign at least once per year [49]. Factors identified as barriers to 
community pharmacists’ involvement in delivery of health promotion and education campaigns 
included lack of time, poor training, lack of physical space, and inadequate knowledge and skill specific 
to the target subject [45], [46], [47], [48]. 
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Health Screening and Disease Prevention Activities 
Several published studies demonstrate the effectiveness of community pharmacy-based disease 
screening in promoting early detection and identification of patients at risk of stroke[50], diabetes[51], 
diabetes and hypertension[52],[53], sleep disorders[54],[55], cardiovascular risk[56],[57],[58],[59] 
and HIV[60]. A screening programme involving 30 pharmacies and 1,145 participants in Canada 
showed that an integrated stroke screening programme identified a high prevalence of individuals 
who could benefit from stroke-prevention therapies [50]. High-risk participants in the study were 
offered lifestyle advice and counselling, and were referred for confirmatory testing with a physician. 
Three months’ follow-up showed 17% of participants identified as at risk of atrial fibrillation (AF) 
started on treatment with an anticoagulant and 50% had improved blood pressure, while 71% had 
confirmatory diabetic testing. Similar findings were shown in a diabetes screening programme in 
Australia [51] and a combined diabetic and hypertension screening programme in Germany [52]. The 
Australian study showed that screening for diabetic risk factors combined with capillary blood glucose 
testing in community pharmacies improved the rate of diagnosis for the disease (P =0.008) and 
resulted in fewer and higher uptake of referrals to GPs[51]. The findings were similar to that of the 
study conducted in Germany that was effective in identifying up to 190 participants with high blood 
pressure referring them for further assessment and treatment [52]. 
One RCT that included health screening, lifestyle advice and follow-up showed a 21% difference in 
change in risk for cardiovascular events (P <0.001) at three months, along with changes in low-density 
lipoprotein cholesterol, systolic blood pressure and glycosylated haemoglobin (HbA1c 0.2mmol/l, 
9.37mmHg, 0.92%, respectively [P <0.001]) in the intervention group[57]. A similar study also 
demonstrated a statistically significant improvement in the knowledge of cardiovascular disease risk 
factors at follow-up, with almost half of the identified high-risk subjects reporting lifestyle changes or 
being started on a medication following referral to their GP [56]. 
Other studies also suggest that a community pharmacy-based intervention involving health promotion 
and screening for cardiovascular risk factors increased access and was effective in early identification 
of at-risk patients when combined with follow-up confirmatory testing[58],[59]. A pilot project in the 
United States that tested the feasibility of offering a rapid, point-of-care HIV testing service showed 
that availability of the service in community pharmacies and retail clinics was a feasible model [60]. In 
addition, the study confirmed that staff at community pharmacies and retail clinics were willing and 
able to provide confidential HIV testing to clients [60]. An Australian study that developed, 
implemented and evaluated a community pharmacist-led sleep health and screening programme 
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(n=325) identified 44% of the target population to be at risk of one or more sleep disorders [54]. 
Further diagnosis from the referrals provided showed that community pharmacists could raise 
awareness and assist in initiating behavioural changes in those at risk of developing a sleep disorder 
[54]. A related study showed that the intervention was associated with higher odds of undergoing a 
diagnostic test for sleep disorders (adjusted OR: 2.24; 95% CI: 1.25–4.01) [61]. A qualitative study of 
participants’ views of an AF screening service using an electrocardiogram (ECG) app in community 
pharmacies in Australia suggests that the service is acceptable, easy to use and feasible. However, the 
authors mentioned that the service would only be sustainable if adequately remunerated and 
combined with other cardiovascular screening services [62]. A UK study assessing current practice, 
knowledge and attitudes demonstrated that there is untapped potential for community pharmacists 
to become a focus for advice and information relating to prevention of HIV and hepatitis B and C [63]. 
Vaccination and Immunization  
A retrospective study demonstrates an increase in vaccination coverage rate from 35.8% to 41.8% (P 
<0.001) for those aged 5 years and under, and 9.8% (P <0.001) for individuals aged 65 years and older 
in the province of Nova Scotia, Canada, one year after a policy change that allowed community 
pharmacists to administer influenza vaccine[64]. Similar findings were reported by another study that 
showed a 2.2% increase in influenza vaccine coverage and in individual likelihood of uptake (adjusted 
prevalence ratio: 1.05; 95% CI 1.02–1.08) [65]. A literature review of 47 studies from the United States 
suggested that increased uptake and coverage for adult vaccination at community pharmacies was 
facilitated by regulatory changes and training programmes that allowed community pharmacists to 
administer vaccines [20]. The review also showed that vaccination services at community pharmacies 
were generally acceptable to patients, and could improve vaccination rates and increase coverage. 
The findings of surveys from the United States [66], UK [67] and Canada [68] indicate that community 
pharmacists were positive about providing vaccination services, but reported adequate training, 
remuneration and a collaborative relationship with general practitioners as factors that would 
improve implementation and uptake of the service. 
Alcohol Dependence Advice and Drug Misuse Services 
A review of two RCTs showed limited evidence on the effectiveness of community pharmacy-based 
alcohol dependence advice and counselling services [18]. The two studies involved provision of a brief 
alcohol advice service in a community pharmacy, compared with usual care. One of the studies (n=407) 
showed no difference in the alcohol use disorder identification test (AUDIT) score (–0.57; 95% CI: –
1.59 to –0.40) between the intervention and control group, while the other (n=69) showed no 
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statistically significant difference in the fast alcohol screening tool (FAST) score (–1.84; 95% CI: —4.49 
to –0.82) [18]. Similar findings were reported by another review of three studies showing that while 
there was a reduction in alcohol consumption in the intervention arm, it was not statistically significant 
[69]. 
Another intervention study showed poor uptake of the service with 21% of eligible participants 
agreeing to the service [70], although the study findings also demonstrated a significant reduction in 
seven-day alcohol unit consumption but no reduction in AUDIT scores [70]. A cross-sectional survey 
showed that while community pharmacists generally had positive views about their roles as providers 
of alcohol dependence advice services[71],[72], direct practice involvement was limited, with one 
study reporting just 5% of the respondents provided the service[39],[40]. 
Lack of knowledge and confidence in providing the service were identified as barriers[71], a finding 
that is similar to that from another survey involving community pharmacists in New Zealand and 
England[73]. A study from the United States, that recruited and screened a convenience sample of 
patients with the use of a tablet computer-based assessment protocol, showed a high prevalence of 
drug misuse in the study population and considered the feasibility of implementing regular opioid 
misuse screening protocols within community pharmacies[74]. Taken together, these studies indicate 
the viability of providing alcohol dependence advice and drug misuse services in community 
pharmacies, although further studies on effectiveness are needed. 
Emergency Hormonal Contraception and Sexual Health  
Three reviews demonstrated increased access to emergency hormonal contraceptives through 
community pharmacists’ involvement in service provision, with a survey of user perception showing 
that the service was rated highly[26],[27],[75]. The review by Anderson et al. also reported an 
association between an observed reduction in attendance at the accident and emergency unit for 
emergency hormonal contraceptives services and availability in community pharmacies [75]. An 
evaluation of a Chlamydia testing service showed that service users valued the speed and convenience 
of accessing this through the community pharmacy, with 16% of the participants indicating they would 
not have taken up the service otherwise [76]. The review by Anderson et al. also showed that window 
displays were effective for raising client awareness of the availability of the service [27]. One survey 
that explored community pharmacists’ views and perceptions as providers of sexual health services 
reported that the respondents were generally positive, but suggested that a lack of appropriate 
training, and inadequate knowledge and skills, limited implementation[77]. 
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Cost effectiveness of public health role of community pharmacists.  
A report by the UK Pharmaceutical Services Negotiating Committee indicates 12 services carried out 
by community pharmacies that delivered £3.0bn in savings in 2015, offsetting the £2.8bn of total 
funding from the Department of Health [78]. Self-care support contributed the largest share of overall 
value at 40%, followed by 31% for medicines support and 29% for public health [78]. Cost savings from 
community pharmacists’ public health activities are also supported by the findings of other reports 
[79], [80], which show that the cost of treating common ailments, such as head lice, threadworms and 
athlete’s foot, in community pharmacies was significantly lower at around £29.30 per patient, 
compared with £147.09 per patient to treat the same ailments at accident and emergency units and 
£82.34 per patient at GP surgeries [79]. 
A UK study that screened patients at risk of chronic obstructive pulmonary disease (COPD) with 
validated tools reported that smoking cessation initiatives provided by community pharmacists gave 
a projected life gain of 38.62 years, 19.92 quality-adjusted life years (QALY) and a cost saving of 
£392.67 per patient screened [81]. A related study that evaluated the effect of a community 
pharmacy-based COPD service on patient outcomes reported significant improvements in patient 
adherence, utilisation of rescue packs, quality of life and a reduction in the number of routine GP visits 
[82], with the intervention cost offset by reductions in the use of other NHS services (GP, accident and 
emergency visits, and hospital admissions) [82]. Similar findings were reported by a smoking cessation 
service that showed overall cost savings to the healthcare system and life gains of 0.18 years for men 
and 0.24 years for women in Thailand [83]. This was also in line with a modelling estimate from a 
simulated sleep disorder screening service provided by community pharmacists that showed an 
estimated maximal incremental cost of €455 (£398.56) per QALY gained [84]. Another study that 
aimed to extend AF screening via a community pharmacy-based intervention using an iPhone ECG 
showed an incremental cost-effectiveness ratio of AU$5,988 (£2,753.17) per QALY and AU$30,481 
(£14,013.85) for preventing one stroke. Sensitivity analysis indicates that cost-effectiveness of the 
intervention improved with increased treatment adherence [85]. 
Barriers to the public health role of community pharmacists 
A number of barriers to community pharmacists’ involvement in public health activities have been 
identified [86]. These include the community pharmacy environment, which sometimes may not be 
suitable for the delivery of public health services — particularly with respect to privacy and 
confidentiality — as well as the perceptions of both the general public and other health providers of 
pharmacists’ competencies[26], [87], [88], [89]. These barriers have also been reported in relation to 
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provision of weight management [39], [40]; prevention of HIV, and hepatitis B and C [63]; and smoking 
cessation services [31]. Time pressure and high dispensing workload were also identified by studies 
on smoking cessation [31], flu vaccination uptake [67] and alcohol advice services [72]. Regulatory 
policies, inadequate training and lack of reimbursement for services were identified as barriers to 
public health service provision in community pharmacy by three UK studies [87], [88],[89]. Inadequate 
knowledge and skills specific to the target subject were also reported as limiting community 
pharmacists’ involvement in delivery of health promotion and education campaigns[45], [46], [47], 
[48], weight management[38], sexual health[77] and alcohol dependence advice services[71]. Other 
challenges faced by community pharmacists included the structure and layout of community 
pharmacies[90], a lack of a well-defined career structure and progression channels, unacceptable 
work-life balance (leading to high stress levels)[91], the unavailability of individually contracted 
community pharmacists[92], and the declining ownership of community pharmacies by independent 
pharmacists [88], [93]. 
Strategies that can enhance the public health role of community pharmacists 
The main themes identified in a UK study that could enhance the role of community pharmacists were: 
enhancing the public health content of the pharmacy training curricula; promoting interdisciplinary 
initiatives in pharmacy education and practice; promoting patients’ self-management capacities and 
pharmacists’ involvement through policies; remunerating pharmacists directly for providing public 
health services; and advancing the pharmaceutical public health practice experience of students [87]. 
These findings were also confirmed in other UK studies[94],[95], with evidence from the literature on 
specific public health interventions included in this paper showing that training[34], availability, access 
to, and familiarity with guidelines [34], [35] improved community pharmacists’ knowledge, thus 
facilitating their involvement in providing public health services. 
Discussion  
The literature demonstrates that community pharmacy-based public health interventions have 
benefitted five key areas: smoking cessation, health promotion, disease screening and preventive 
activities, provision of emergency hormonal contraceptives, and vaccination services. There was 
mixed evidence with respect to the effectiveness of weight-management and alcohol-dependence 
advice interventions; however, the available data do suggest feasibility and acceptability of these 
service owing to the perceived ease of access and convenience[39], [40], [71], [72], [73]. These global 
findings add to the argument for the expansion of the public health roles of community pharmacists, 
as suggested by existing government reports and briefing documents [7], [10], [12]. Heterogeneity in 
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pharmacy-based interventions in areas such as in smoking suggests the need for a standardised 
approach to service provision [18], [19]. This would ensure consistency in the quality of services 
provided [96], [97], [98]. However, it is important to highlight from the included descriptive studies 
that while community pharmacists were generally positive about their public health roles, they 
acknowledged the need for appropriate training targeted to these services. This may entail both 
updating the public health content of undergraduate pharmacy curricula[99],[100] and providing 
continuing professional development designed specifically for these services[34]. Such training would 
also need to be standardised, particularly as reports have shown variations in skill level of graduates 
from different countries as a result of disparities in undergraduate pharmacy training programmes 
[101]. There is also a need for policies that recognise community pharmacists as providers of public 
health services, as well as regulatory guidelines that provide a framework for service provision. This is 
of particular importance in view of emerging evidence from the UK that demonstrates the positive 
impact of government policy and professional guidelines on provision of flu vaccination by community 
pharmacists [102]. Similar findings from Canada and the United States[20],[64],[65] further emphasise 
this point, and are also consistent with evidence indicating that provision of and familiarity with 
practice guidelines facilitates the implementation and effectiveness of public health activities[35]. 
While the pharmacy profession is transitioning towards patient-centred care, with pharmacists 
contributing to micro-level public health activities (such as disease screening and preventive activities), 
there is a need to extend this role to macro-level public health functions, such as involvement in health 
planning, policy development and evaluation [103]. This must be done while also tackling many of the 
identified barriers in the public health role of community pharmacists. 
 
 
Limitations 
Although the authors aimed to provide an overview of the global evidence, the included literature 
were mainly from high-income countries (e.g. the UK, Canada and the United States). As a result, the 
generalisability of these findings to middle- and low-income countries with severe workforce 
shortages is likely to be limited. There were also observed limitations in the studies included in this 
paper. Only two studies in the Saba et al. meta-analysis [19] and five in the review by Brown et al. 
validated self-reported smoking abstinence via biochemical measures [18]. 
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Details on the sampling method used for recruiting participating community pharmacies were also 
lacking in most of the smoking cessation intervention studies. Where reported, pharmacists and 
pharmacy recruitment was mainly via self-selection or purposive sampling — a finding that limits 
generalisability, given the inherent bias. Observed variability in the design of pharmacy-based weight-
management interventions in the included studies biases the overall findings and conclusions. For 
example, the duration of weight-management intervention in the studies in the Brown et al. review 
[18] varied between 15 to 52 weeks. The intervention also involved the use of weight-management 
medication in one study, in contrast to the others that compared a combination of diet, physical 
activity and lifestyle counselling in different settings, including community pharmacies [18]. 
Demographics of study participants also varied between settings in one study [18]— a feature that 
further confounds the overall findings reported. Only one study on the effectiveness of pharmacy-
based health promotion and educational campaigns included in this paper provided specific details on 
the implementation of the intervention [43]. Where provided, the intervention involved the use of a 
convenience sample, further limiting generalisability. In addition, the studies on pharmacists’ 
contribution to vaccination and immunisation [20] were primarily observational, with just one RCT 
included. This suggests limitations in internal validity and challenges with inferring causality, especially 
given the outcome measure of self-reported vaccination status [20]. Similar limitations were also 
observed in the studies on emergency hormonal contraception [75]. The difficulties in recruitment 
into one of the studies that evaluated the effectiveness of pharmacy-based alcohol advice services 
indicate that the research [70] was not statistically powered to detect an effect. Consequently, further 
work in this area is needed to explore factors that could improve uptake of the service. In general, the 
non-random sampling approach used in the recruitment of participating community pharmacists and 
pharmacies, as well as the small sample size in most of the descriptive studies, is another source of 
bias and suggests that the views of the respective study participants may not be representative. 
Furthermore, evidence from the included studies must be interpreted in relation to the healthcare 
context in the respective countries, and therefore may not be generalisable to other countries with 
different healthcare systems. Overall, the evidence demonstrates that pharmacists are capable of 
providing both population-based and individual level public health services. However, strategies that 
can help facilitate and enhance community pharmacists’ public health roles are needed. 
Conclusion 
This article discusses global evidence of community pharmacists’ contributions to public health in the 
areas of smoking cessation, weight management, health education and promotion, disease screening 
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and prevention, vaccination and immunisation, alcohol and drug misuse, and sexual health. There is 
evidence of cost savings resulting from community pharmacists’ providing some of these services, but 
additional studies are needed to confirm the cost-effectiveness of all services, as well as whether the 
models proposed can be translated between different healthcare systems. However, time pressure, 
excessive workload, inadequate training, a poor community pharmacy environment, and a lack of 
reimbursement, among other factors, have been identified as barriers in the delivery of these roles. 
There is a need to address these in order facilitate efficient and effective delivery of these services by 
community pharmacists. Enhancing the public health content of undergraduate pharmacy curricula, 
remunerating pharmacists adequately and designing appropriate continuing professional 
development programmes are strategies that can enhance public health services delivered by 
community pharmacists. 
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